Home › DexCom Announces Appointment of Mark G. Foletta as Board Member
 

Keywords :   


DexCom Announces Appointment of Mark G. Foletta as Board Member

2014-11-20 13:05:04| Steel - Topix.net

Mr. Foletta currently serves on the board of directors of AMN Healthcare Services and Regulus Therapeutics. Previously, Mr. Foletta served as Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc. from 2006 to August 2012 during the growth of Amylin's diabetes and obesity franchises, including the commercial launch of diabetes drugs BYDUREONA , BYETTAA and SYMLINA .

Tags: member board mark appointment

Category:Materials

Latest from this category

All news
»
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05'I had no choice but to get a 35-year mortgage'
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Businessman Tony O'Reilly dies after short illness
18.05Eastern North Pacific Tropical Weather Outlook
More »